Navigation Links
Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
Date:7/7/2009

gen environments (such as the damaged areas of the heart), they are committed to becoming muscle, and they are the only progenitor cell in the human body that normally develop the ability to contract making them more likely to restore contractile function of the damaged heart.

About Bioheart, Inc.

Bioheart, Inc. is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to improve a patient's quality of life and reduce health care costs and hospitalizations. Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell(R), is an innovative clinical muscle-derived stem cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. The Company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell Therapy, an autologous, adipose tissue-derived stem cell treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy utilizing autologous cells that are genetically modified to express additional potentially therapeutic growth proteins. For more information on Bioheart, visit www.bioheartinc.com.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could,"
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
2. New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer
3. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
4. Dr. James F. Pingpank to Present at Leading Regional Therapies Conference
5. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
6. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
7. Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
8. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
9. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
10. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
11. Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)...   DaVita HealthCare Partners Inc.  (NYSE: ... and most innovative health care communities, today announced ... Clinical Research  (DCR) and  HealthCare Partners Clinical Research , ... clinical research and data analytics services, specifically in ... renal disease (ESRD), as well as primary care ...
(Date:12/14/2014)... -- ChartSpan, a consumer platform for patients managing healthcare records, ... app in the United States . ... ChartSpan is an iPhone and iPad app empowering ... electronic healthcare records. The product was built by a ... for the healthcare system to deliver on the promise ...
(Date:12/13/2014)... 12, 2014  Radiologists can transmit their reports, ... their referring physicians, electronic health records (EHR) systems ... technology.  That was the message ... (ADS) at the recent Radiology Society of North ... radiology reports in this manner also helps referring ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3
... NANJING , China, May 18 /PRNewswire-Asia/ ... SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, ... reported preliminary,unaudited financial results for the quarter ended March ... -- Total revenue was RMB458.7 million (US$67.2 million) ...
... NEW YORK , May 17 Reportlinker.com announces that a new market research ... , Global HIV Drugs industry ... http://www.reportlinker.com/p0197175/Global-HIV-Drugs-industry.html , ... analyzes the Worldwide markets for HIV Drugs in US$ Million. The report provides separate comprehensive ...
Cached Medicine Technology:Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 2Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 3Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 4Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 5Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 6Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 7Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 8Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 9Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 10Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 11Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 12Reportlinker Adds Global HIV Drugs industry 2Reportlinker Adds Global HIV Drugs industry 3Reportlinker Adds Global HIV Drugs industry 4Reportlinker Adds Global HIV Drugs industry 5Reportlinker Adds Global HIV Drugs industry 6Reportlinker Adds Global HIV Drugs industry 7Reportlinker Adds Global HIV Drugs industry 8Reportlinker Adds Global HIV Drugs industry 9Reportlinker Adds Global HIV Drugs industry 10Reportlinker Adds Global HIV Drugs industry 11Reportlinker Adds Global HIV Drugs industry 12Reportlinker Adds Global HIV Drugs industry 13Reportlinker Adds Global HIV Drugs industry 14
(Date:12/17/2014)... -- As gas prices rose in recent years, so ... In times of gas increases, more people start ... the researchers explained. They examined data gathered between ... number of motorcycle registrations in the United States and ... analysis revealed a strong association between rising gas prices ...
(Date:12/17/2014)... Greater participation in music classes may benefit children,s language ... in the nonprofit Harmony Project, which provides music education ... Over two years, children who actively participated in the ... speech and reading, compared to those with lower levels ... in music classes occurred in the same areas of ...
(Date:12/15/2014)... A recent survey found that the most ... skin health and beauty were: “Connections,” “climate,” “career” and ... and health advocate and radio host Sharon Kleyne agrees ... survey and the Four C’s.* Kleyne notes, however, that ... would benefit from paying attention to one’s daily fresh ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 South Florida’s leading ... that holidays can be a daze of hassle, hustle, and ... falls while decking halls, to burns when making special meals ... hazards that can happen at any time. To prevent this ... Now has made a list of helpful and healthful holiday ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... study should reassure the millions of American women who have ... cancer. "There is no association between migraine and breast ... of medicine at Harvard Medical School. "There is no positive ... is no protective effect either." About 18 percent of ...
Breaking Medicine News(10 mins):Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... formed Brain Science Institute,s NeuroTranslational Program has entered ... Inc. to discover and develop small molecule glutamate ... NeuroTranslational Program was launched in 2009 staffed with ... with Johns Hopkins faculty to help translate basic ...
... suggests that poverty and lack of insurance contribute to the ... adults with moderate to severe chronic kidney disease are far ... with the disease, a new U.S. study has found. , ... adults who had non-dialysis, chronic kidney disease, stages three to ...
... Gary A. Puckrein released the following statement.  , ... , , ... ... "We applaud the steps taken by the Congressional Black Caucus and the White House ...
... March 12 Cost-effective technology that allows products to be traced through the U.S. ... Intelligent Global Pooling Systems (iGPS Company LLC) announced today. iGPS urged the U.S. Senate to mandate ... ... ...
... frank talk with your doctor, researchers say , FRIDAY, ... have different expectations for knee and hip replacement surgery, ... a new study shows. , Hospital for Special Surgery ... their doctors and found clinically meaningful disagreement in 68 ...
... ... and Affiliated Clinicians , ... CA (Vocus) March 12, 2010 -- U.S. HealthWorks , one of the nation’s largest ... needs, today announced that the company will host its 2nd healthcare symposium for U.S. HealthWorks ...
Cached Medicine News:Health News:U.S. Minorities Especially Vulnerable to Kidney Failure 2Health News:Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness 2Health News:Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness 3Health News:Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness 4Health News:Massive Food Flavoring Recall Underscores Need for New Tracking Technology to Contain Outbreaks of Foodborne Illness 5Health News:Knee Surgeon's Expectations May Differ From Yours 2Health News:U.S. HealthWorks Hosts Healthcare Symposium 2
Transparent film for easy visual monitoring of samples...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
DMSO-resistant microplate sealing film...
Medicine Products: